GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial ...

In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...

Santa Monica-based prescription medication discount provider GoodRx Holdings Inc. wants its customers and other medication ...

The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...

We recently compiled a list of the 10 Best Affordable Stocks Under $5 to Buy Now. In this article, we are going to take a ...

The combination of just Medicare premiums and co-pays “eat up about one-third of Social Security income and one-fifth of ...

Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.57 which represents a slight increase of $0.15 or 3.39% from the prior close of $4.42. The stock opened at $4.41 and touched ...

Healthcare leaders shared insights on various topics, including industry challenges, a new administration and growing their ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. In ...

On Wednesday, the Food & Drug Administration (FDA) banned red dye No. 3 from all food products in the United States due to potential cancer risk, but this raises an important ...

Rising drug prices remain a contentious issue in the US. Credit: Malte Mueller via Getty Images. At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted ...